monotherapy – Page 10 – Communicable Diseases Research

Clinical course and challenging management of early COVID-19 infection after heart transplantation: case report of two patients

심장 이식 후 초기 COVID-19 감염의 임상 경과 및 어려운 관리: 2명의 환자에 대한 증례 보고

Case Reports

Published on 2021-01-202022-09-10
Journal: BMC Infectious Diseases [Category] MERS, 치료제,

Ozone therapy in COVID-19: A narrative review

COVID-19의 오존 요법: 내러티브 검토

Review

Published on 2021-01-022022-09-11
Journal: Virus research [Category] 치료제,

[키워드] Acute coronary syndrome acute coronary syndromes adjunct administration alternative Antiviral antiviral activity antiviral drug antiviral drugs applicability article Autohaemotherapy Blood Combination Combined combined treatment COVID-19 COVID-19 treatment cytokine Cytokines database demonstrated Diseases enhancer Evidence gamma interferon hospital identify immune Immunity immunological inactivation Inflammation interferon interferons intravenous Italian lung damage methodology modulation monotherapy oxygen Ozone Ozone therapy Patient patients with COVID-19 Pneumonia protocols pulmonary pulmonary diseases reduction in reperfusion SARS-CoV-2 pneumonia selected Society standard treatment systemic therapeutic therapy Treatment Viral viral replication viruses website were used
[DOI] 10.1016/j.virusres.2020.198207 PMC 바로가기 [Article Type] Review

[A retrospective analysis of medication in children with SARS-CoV-2 infection in Wuhan, China]

[중국 우한에서 SARS-CoV-2 감염 아동의 약물치료 후향적 분석]

Article

Published on 2021-01-012022-09-11
Journal: Zhongguo dang dai er ke za zhi = Chinese journal o [Category] 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Antiviral antiviral drug antiviral drugs antiviral therapy Asymptomatic Azithromycin children Chinese clearance Clinical practice Combination coronavirus diagnosed English enrolled Hospital stay Infection interferon median median age medication monotherapy nucleic acid regimen respiratory Retrospective analysis SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nucleic acid severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 subgroup subgroup analysis subgroups symptomatic therapy treated was performed was used Wuhan Wuhan, China
[DOI] 10.7499/j.issn.1008-8830.2007212 PMC 바로가기 [Article Type] Article

A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment

코로나19 치료에서 클로로퀸과 하이드록시클로로퀸 단독요법 또는 아지스로마이신과의 병용요법에 대한 체계적인 검토 및 메타분석

Meta-Analysis

Published on 2020-12-172022-09-10
Journal: Scientific Reports [Category] SARS, 임상, 치료법, 치료제,

[키워드] 95% CI 95% confidence interval Analysis article Azithromycin calculated can not carried Chain Reaction Chloroquine CIs Combination coronavirus COVID-19 cure rate database Diseases drug side effects Effect Effectiveness examined exposure to Future good quality group HCQ Hospital stay Hydroxychloroquine IMPROVE Infectious diseases investigated mechanical ventilation Meta-analysis meta-regression monotherapy Mortality mortality rate not differ not different observational studies observational study Patient PCR polymerase chain polymerase chain reaction radiological improvement radiological progression random-effects model randomized control trial RCT relative risks reported risk RRs scarcity side Side effects significantly significantly higher standard care statistically systematic review treating COVID-19 Treatment Viral viral infection was performed worsening
[DOI] 10.1038/s41598-020-77748-x PMC 바로가기 [Article Type] Meta-Analysis

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Articles

Published on 2020-12-172022-10-31
Journal: International Journal of Environmental Research an [Category] COVID-19,

[키워드] 95% CI ACEi ACEIs Acute kidney injury acute respiratory distress Affair Affect Algorithm analyses angiotensin receptor blocker approach ARB ARBs association baseline blocker calibrated CCBs center Characteristics clinically Cohort cohort analysis Columbia University Combination combination therapy Comparisons Control COVID-19 COVID-19 diagnosis COVID-19 in patient data-driven decrease defined demonstrated Department determine development diuretics Effects Electronic health record enzyme European experiment finding funding generalisability generate hazard ratio heterogeneity hospital Hospital admission hypertension identify increased risk inhibitor International IQVIA janssen Korean lower risk Medical Research Council medications meta-analysed Ministry of Health monotherapy negative control network no significant difference observational study Older outcome partnership Patient patient cohort Pneumonia receiving Registered renin–angiotensin system risk risk of COVID-19 Sepsis South Spain susceptibility syndrome System Treatment USA user veteran Welfare Wellcome Trust with COVID-19
[DOI] 10.1016/S2589-7500(20)30289-2 PMC 바로가기 [Article Type] Articles

A retrospective comparison of drugs against COVID-19

Comparative Study

Published on 2020-12-142022-10-04
Journal: Virus research [Category] MERS, SARS, 신약개발, 진단, 치료기술, 치료제,

Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Research Article

Published on 2020-11-162022-10-28
Journal: BMC Medicine [Category] COVID-19, SARS,

[키워드] 1:1 accompany Admission adverse outcome adverse outcomes association Characteristics cohort of patient cohort study Combination Coronavirus disease 2019 COVID-19 COVID-19 patient diabete Dipeptidyl peptidase-4 drugs evaluate evaluated Evidence Glucose-lowering drug hospital Hospital stay ICU admission In-hospital in-hospital complication In-hospital death information inhibitor inhibitors insulin intensive care internal invasive Limited Logistic regression logit mechanical ventilation monotherapy Mortality multicenter Non-invasive outcome Patient patients with COVID-19 propensity score matching Prospective Study registry Result Sample size selected Society Spain Spanish standardized mean difference study outcomes Treatment type 2 diabete Type 2 diabetes mellitus were used
[DOI] 10.1186/s12916-020-01832-2 PMC 바로가기 [Article Type] Research Article

Potential role of interferons in treating COVID-19 patients

Review

Published on 2020-11-032022-11-01
Journal: International immunopharmacology [Category] COVID-19, SARS,

[키워드] Abstract accelerated acute respiratory distress acute respiratory syndrome ARDS Asymptomatic bat breathlessness Care Contact coronavirus cough COVID-19 COVID-19 disease COVID-19 patients death Developing diagnose disease droplet effective effective therapy fatigue Fever home quarantine hospitals Human IFN IFNs immunological information interferon Isolation malaise manuscript Mild MODS monotherapy multiple organ dysfunction outbreak pandemic patients performed Pneumonia Potential Prevent prevention public health Respiratory Coronavirus SARS-CoV-2 severe respiratory disease shown sore throat supported Symptom syndrome the SARS-CoV-2 therapy transported treating COVID-19 patient Treatment Virological virus with COVID-19
[DOI] 10.1016/j.intimp.2020.107171 PMC 바로가기 [Article Type] Review

The Emerging Role of Vitamin C in the Prevention and Treatment of COVID-19

Editorial

Published on 2020-10-272022-10-31
Journal: Nutrients [Category] COVID-19, MERS, SARS,

[키워드] acute respiratory distress syndrome administration affecting Anti-inflammatory antioxidant Antithrombotic appear Ascorbate ascorbic acid carried China country COVID-19 Critically ill patient decrease decreased mortality deficiency Efficacy effort elevated Evidence functions greater group IMPROVE include indicated Intervention intravenous investigation low-middle-income monotherapy Mortality observational study optimization overlap oxidative stress Patient patients with COVID-19 patients with pneumonia physiological functions plasma pleiotropic Pneumonia Population prevention protocol Randomized controlled trial Randomized controlled trials RCT RCTs reduce Registered Research risk factor Risk factors role safety profile Sepsis severe coronavirus disease severe respiratory infections severely ill patient severity significantly sustained the disease translation Treatment Trial trials Vitamin Vitamin C with COVID-19
[DOI] 10.3390/nu12113286 PMC 바로가기 [Article Type] Editorial

Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19

Perspective Piece

Published on 2020-10-212022-10-28
Journal: The American Journal of Tropical Medicine and Hygi [Category] COVID-19, MERS, SARS,